Search by Drug Name or NDC
NDC 63323-0241-20 Glycophos 216 mg/mL Details
Glycophos 216 mg/mL
Glycophos is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is SODIUM GLYCEROPHOSPHATE ANHYDROUS.
Product Information
| NDC | 63323-0241 |
|---|---|
| Product ID | 63323-241_aeed61b6-c0c3-416d-be37-991dd58a4950 |
| Associated GPIs | 79600018002010 |
| GCN Sequence Number | 058012 |
| GCN Sequence Number Description | sodium glycerophosphate VIAL 1 MMOL/ML INTRAVEN |
| HIC3 | C1P |
| HIC3 Description | PHOSPHATE REPLACEMENT |
| GCN | 23316 |
| HICL Sequence Number | 016695 |
| HICL Sequence Number Description | SODIUM GLYCEROPHOSPHATE |
| Brand/Generic | Brand |
| Proprietary Name | Glycophos |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SODIUM GLYCOLATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 216 |
| Active Ingredient Units | mg/mL |
| Substance Name | SODIUM GLYCEROPHOSPHATE ANHYDROUS |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0241-20 (63323024120)
| NDC Package Code | 63323-241-20 |
|---|---|
| Billing NDC | 63323024120 |
| Package | 10 VIAL, PLASTIC in 1 CARTON (63323-241-20) / 20 mL in 1 VIAL, PLASTIC |
| Marketing Start Date | 2013-05-13 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |